EdU Imaging Kits (HF488)
Measuring cell proliferation and cell cycle are a fundamental method to assess cell health, determine genotoxicity, and evaluate drug’s pharmacodynamic effect. The common method is measuring DNA synthesis directly. In previous experiments, there are several approaches such as the incorporation of radioactive nucleosides (3H-thymidine) or BrdU. Here, we introduce one new method, click chemistry-CuAAC (Copper-Catalyzed Azide-Alkyne Cycloaddition), and the use of this reaction in direct measurement of S-phase DNA synthesis in cell cycle.
A nucleoside analog of thymidine, EdU (5-ethynyl-2’-deoxyuridine), can be incorporated into DNA strand during DNA synthesis. The alkynyl group of EdU is a biologically inert group that will undergo an extremely selective reaction with dye’s azido via a CuAAC reaction to afford an 1,2,3-triazole product. EdU and HyperFluor™ 488 azide possess biologically unique moieties to label DNA of proliferating cells, producing low backgrounds and high detection sensitivities. This CuAAC reaction affords superior regioselectivity and quantitative transformation under extremely mild conditions.
EdU Imaging Kits (HF488) specifically labels the DNA of proliferating cells after HyperFluor™ 488 azide is ligated to EdU, then the proliferating cells can be detected by a microscope or flow cytometry.


- 1. Yuxi Lin, Feng Zhang, Weimin Guo. "Hyperbaric oxygen targets RCN1 to modulate ER-mitochondria crosstalk and ameliorate sorafenib resistance in hepatocellular carcinoma." Drug Resist Updat . 2025 Dec 8:85:101342. PMID: 41385809
- 2. Zixuan Chen, Yu Zhang, et al. "Gingerenone A inhibits LDHA-mediated glycolysis and restores sunitinib sensitivity in renal cell carcinoma." Biochem Pharmacol. 2025 Nov 26:117563. PMID: 41314434
- 3. Wen Wen, Rui Wang, et al. "Consensus artificial intelligence-driven prognostic signature for predicting the prognosis of hepatocellular carcinoma: a multi-center and large-scale study." NPJ Precis Oncol. 2025 Jul 1;9(1):207. PMID: 40595395
- 4. Zixuan Chen, Xing Jia, et al. "A novel peptide TCL6148 induces ferroptosis via the GOT1/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma." Int J Biol Macromol. 2025 Jun:313:144242. PMID: 40379184
- 5. Kai Meg, Zixuan Chen, et al. "Unraveling the mechanisms of tricetin in renal cell carcinoma treatment through network pharmacology and experimental validation." Med Oncol. 2025 May 3;42(6):192. PMID: 40319129
- 6. Zixuan Chen, Chengtao Han, et al. "2‐Undecanone induces ferroptosis via the STAT3/GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib." Biofactors. 2025 Mar-Apr;51(2):e70016. PMID: 40200786
- 7. Shuhan Liu, Shijie Lv, et al. "The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma." Front Oncol. 2024 Aug 14:14:1409620. PMID: 39206152
- 8. Zixuan Chen, Xing Jia, et al. "AUY922 Improves Sensitivity to Sunitinib in Clear Cell Renal Cell Carcinoma Based on Network Pharmacology and in Vitro Experiments." Heliyon. 2024 Jul 18;10(14):e34834. PMID: 39149033
| Components | 50-500 Tests |
| EdU (Component A) | 5 mg |
| HyperFluor™ 488 azide (Component B) | 1 vial |
| DMSO (Component C) | 4 mL |
| 10X EdU Reaction Buffer (Component D) | 4 mL |
| CuSO4 (100 mM Aqueous Solution) (Component E) | 1 vial |
| EdU Buffer Additive (Component F) | 400 mg |
| Hoechst 33342 (10 mg/mL in Water) (Component G) | 35 μL |
Store the kit at -20ºC away from light and moisture, stable for 1 year. | |









